Short term treatment of KPN tumor-bearing mice with CXCR2sm resulted in reduced neutrophil counts in both the peripheral blood and primary tumors (Figures 5J and 5K), and an increase in CD8+ T cell numbers, compared with vehicle-treated counterparts (Figures 5K and S6C–S6E). This evidence concerns the gene CD8A and neoplasm.